Profile | GDS5420 / 214593_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 17.22 | 16 |
GSM1296119 | B_lesional_pre-dose | 70.47 | 34 |
GSM1296076 | C_lesional_pre-dose | 132.12 | 47 |
GSM1296092 | D_lesional_pre-dose | 103.09 | 44 |
GSM1296103 | E_lesional_pre-dose | 9.88 | 11 |
GSM1296078 | F_lesional_pre-dose | 138.65 | 48 |
GSM1296107 | G_lesional_pre-dose | 84.03 | 37 |
GSM1296109 | H_lesional_pre-dose | 60.19 | 32 |
GSM1296080 | I_lesional_pre-dose | 42.94 | 30 |
GSM1296090 | J_lesional_pre-dose | 192.06 | 53 |
GSM1296074 | K_lesional_pre-dose | 73.32 | 39 |
GSM1296111 | L_lesional_pre-dose | 136.54 | 45 |
GSM1296099 | M_lesional_pre-dose | 32.07 | 24 |
GSM1296086 | O_lesional_pre-dose | 148.66 | 49 |
GSM1296117 | P_lesional_pre-dose | 115.43 | 42 |
GSM1296113 | Q_lesional_pre-dose | 117.05 | 41 |
GSM1296096 | R_lesional_pre-dose | 27.6 | 23 |
GSM1296105 | S_lesional_pre-dose | 55.13 | 32 |
GSM1296098 | T_lesional_pre-dose | 67.56 | 34 |
GSM1296101 | U_lesional_pre-dose | 19.12 | 17 |
GSM1296121 | V_lesional_pre-dose | 64.17 | 33 |
GSM1296088 | W_lesional_pre-dose | 111.03 | 44 |
GSM1296082 | X_lesional_pre-dose | 135.65 | 48 |
GSM1296115 | Y_lesional_pre-dose | 116.88 | 43 |
GSM1296084 | Z_lesional_pre-dose | 123.71 | 45 |
GSM1296072 | B_lesional_day8 | 70.94 | 34 |
GSM1296069 | L_lesional_day8 | 194.97 | 50 |
GSM1296071 | P_lesional_day8 | 102.2 | 39 |
GSM1296070 | Y_lesional_day8 | 118.44 | 41 |
GSM1296073 | V_lesional_day8 | 57.95 | 32 |
GSM1296034 | A_lesional_day15 | 36.03 | 25 |
GSM1296041 | G_lesional_day15 | 117.31 | 43 |
GSM1296035 | R_lesional_day15 | 0.92 | 1 |
GSM1296038 | U_lesional_day15 | 53.84 | 32 |
GSM1296047 | B_lesional_day15 | 77.02 | 35 |
GSM1296039 | E_lesional_day15 | 52.58 | 32 |
GSM1296042 | H_lesional_day15 | 121.89 | 42 |
GSM1296043 | L_lesional_day15 | 116.77 | 41 |
GSM1296037 | M_lesional_day15 | 17.11 | 14 |
GSM1296046 | P_lesional_day15 | 163.71 | 47 |
GSM1296044 | Q_lesional_day15 | 124.03 | 42 |
GSM1296045 | Y_lesional_day15 | 132.8 | 43 |
GSM1296025 | C_lesional_day15 | 110.16 | 43 |
GSM1296033 | D_lesional_day15 | 123.21 | 45 |
GSM1296027 | I_lesional_day15 | 103.29 | 44 |
GSM1296032 | J_lesional_day15 | 240.18 | 55 |
GSM1296024 | K_lesional_day15 | 72.13 | 37 |
GSM1296031 | W_lesional_day15 | 148.59 | 47 |
GSM1296028 | X_lesional_day15 | 126.59 | 45 |
GSM1296029 | Z_lesional_day15 | 97.76 | 41 |
GSM1296026 | F_lesional_day15 | 53.78 | 32 |
GSM1296030 | O_lesional_day15 | 77.83 | 40 |
GSM1296040 | S_lesional_day15 | 11.15 | 10 |
GSM1296036 | T_lesional_day15 | 46.71 | 28 |
GSM1296048 | V_lesional_day15 | 57.88 | 31 |
GSM1296059 | A_lesional_day43 | 17.18 | 17 |
GSM1296066 | G_lesional_day43 | 134.35 | 44 |
GSM1296060 | R_lesional_day43 | 53.39 | 32 |
GSM1296063 | U_lesional_day43 | 66.5 | 35 |
GSM1296064 | E_lesional_day43 | 44.55 | 29 |
GSM1296067 | H_lesional_day43 | 69.31 | 33 |
GSM1296062 | M_lesional_day43 | 28.64 | 24 |
GSM1296068 | Q_lesional_day43 | 152.27 | 45 |
GSM1296050 | C_lesional_day43 | 177.11 | 50 |
GSM1296057 | D_lesional_day43 | 44.08 | 30 |
GSM1296052 | I_lesional_day43 | 134.09 | 47 |
GSM1296054 | J_lesional_day43 | 169.65 | 49 |
GSM1296049 | K_lesional_day43 | 140.46 | 47 |
GSM1296055 | W_lesional_day43 | 44.52 | 28 |
GSM1296053 | X_lesional_day43 | 108.54 | 43 |
GSM1296058 | Z_lesional_day43 | 5.31 | 6 |
GSM1296051 | F_lesional_day43 | 153.23 | 49 |
GSM1296056 | O_lesional_day43 | 26.13 | 23 |
GSM1296065 | S_lesional_day43 | 39.73 | 27 |
GSM1296061 | T_lesional_day43 | 15.86 | 14 |
GSM1296095 | A_non-lesional_pre-dose | 46.3 | 30 |
GSM1296120 | B_non-lesional_pre-dose | 70.8 | 33 |
GSM1296077 | C_non-lesional_pre-dose | 22.33 | 20 |
GSM1296093 | D_non-lesional_pre-dose | 108.99 | 42 |
GSM1296104 | E_non-lesional_pre-dose | 69.3 | 36 |
GSM1296079 | F_non-lesional_pre-dose | 152.98 | 49 |
GSM1296108 | G_non-lesional_pre-dose | 92.43 | 38 |
GSM1296110 | H_non-lesional_pre-dose | 81.41 | 35 |
GSM1296081 | I_non-lesional_pre-dose | 48.33 | 32 |
GSM1296091 | J_non-lesional_pre-dose | 200.47 | 53 |
GSM1296075 | K_non-lesional_pre-dose | 122.71 | 46 |
GSM1296112 | L_non-lesional_pre-dose | 133.98 | 43 |
GSM1296100 | M_non-lesional_pre-dose | 42.34 | 28 |
GSM1296087 | O_non-lesional_pre-dose | 118.76 | 46 |
GSM1296118 | P_non-lesional_pre-dose | 144.66 | 45 |
GSM1296114 | Q_non-lesional_pre-dose | 154.01 | 46 |
GSM1296097 | R_non-lesional_pre-dose | 41.5 | 29 |
GSM1296106 | S_non-lesional_pre-dose | 56.49 | 31 |
GSM1296102 | U_non-lesional_pre-dose | 38.7 | 27 |
GSM1296122 | V_non-lesional_pre-dose | 68.26 | 33 |
GSM1296089 | W_non-lesional_pre-dose | 120.63 | 43 |
GSM1296083 | X_non-lesional_pre-dose | 83.79 | 39 |
GSM1296116 | Y_non-lesional_pre-dose | 151.67 | 45 |
GSM1296085 | Z_non-lesional_pre-dose | 130.6 | 46 |